Sarepta Therapeutics, Inc. SRPT

$SRPT 93% institutional owned per Charles Schwab

$SRPT there’s a boy on IG who had ELEVIDYS 8 years ago. Amazing. Miracle. No words. GLTA

$SRPT stars will align for this one

$SRPT well that’s confirmation. Experimental drug for market cap of an approved drug company. PT 350+

$SRPT no brainer

$SRPT super low volume

$SRPT sad to see Doug leave, but it may be for the best. His mission was to propel company to multiple approved therapies and take it to the moon under SRPT brand. Glad that the FDA fiasco is over. Glad to know he got Roche partially involved in 2019. After Japanese approval comes UK. How many examples do you need Roche?

Doug will still get paid out very well.

$SRPT preliminary reports suggest a major disconnect between cash on hand and revenue. What am I missing?

$SRPT this Adam fagerstein is a big time hater

$SRPT suing Sanofi